Saxenda — Cigna
Weight Loss, Pediatric
Initial criteria
- Patient is age ≥ 12 years and < 18 years; AND
- Patient has engaged in a trial of behavioral modification and dietary restriction for at least 3 months; AND
- At baseline, patient had a BMI ≥ 95th percentile for age and sex; AND
- The medication will be used concomitantly with behavioral modification and a reduced-calorie diet
Reauthorization criteria
- Patient is age ≥ 12 years and < 18 years; AND
- At baseline, patient had a BMI ≥ 95th percentile for age and sex; AND
- Patient has had a reduction in BMI ≥ 1% from baseline; AND
- The medication will be used concomitantly with behavioral modification and a reduced-calorie diet
Approval duration
initial 4 months, reauth 1 year